United States

US Bio-Pharma Company Gilead Sciences buys Oxford Biotech Company MiroBio for $405 Million

US Bio-Pharma Company Gilead Sciences buys Oxford Biotech Company MiroBio for $405 Million

United States, BioTech

US Bio-Pharma Company Gilead Sciences buys Oxford Biotech Company MiroBio for $405 Million

US Bio-Pharma Company Gilead Sciences buys Oxford Biotech Company MiroBio for $405 Million

The best Articles in our Network

Germany

VÆRIDION from Germany raises €14M to develop Zero-Emission Electric Microliner

World’s Inspiring Leaders

The Visionaries behind OnlyFans: Tim Stokely’s Idea and Leonid Radvinsky’s Leadership That Changed the Creator Economy

Canada

Realize Capital Partners commits $32.5M in second Round of Social Finance Fund Investments

United Kingdom

KHP Ventures launches €24.1M NHS-Backed Fund to support Digital Mental Health Startups from Europe

Netherlands

Fluid Biomed raises $27M USD Series A to advance Bioabsorbable Brain Stent Technology

Netherlands

ProQR bags €7.7M to advance RNA Therapy for Rett Syndrome

Previous

Next